Wysa

Bluedrop Medical is a developer of connected diagnostic technology for diabetes-related complications, specifically focused on preventing diabetic foot ulcers. The company's flagship product, OneStep, is an at-home smart foot scanner that captures high-resolution images and temperature data in under 30 seconds per day. The EveryStep monitoring service analyzes scan data to identify and communicate risks to patients and their physicians, enabling early detection and timely intervention. The technology addresses a significant healthcare challenge, as up to 25% of people with diabetes develop diabetic foot ulcers, with treatment costs exceeding $17 billion annually in the United States. Bluedrop's solution achieves an average of approximately four scans per week per patient, with detected ulcers typically graded at Stage 1 at the time of clinical escalation, significantly reducing treatment costs. Founded in 2015 and headquartered in Galway, Ireland, with US operations in Houston, Texas, the company has raised $17.4 million in Series A funding from investors including EIC Fund, Atlantic Bridge, Elkstone, Enterprise Ireland, and Dreamit.